Literature DB >> 15938041

Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.

Michele Dalla Vestra1, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani, Paola Fioretto.   

Abstract

Type 2 diabetes is frequently associated with an inflammatory status; the relationships between low-grade inflammation and diabetic nephropathy are still unclear. The aim of this study was to evaluate the relationships between acute-phase markers of inflammation, glomerular structure, and albumin excretion rate (AER) in type 2 diabetes. In 74 patients with type 2 diabetes (23 normoalbuminuric, 30 microalbuminuric, and 21 proteinuric) fibrinogen, serum amyloid A protein (SAA), C-reactive protein (CRP), and IL-6 were determined. AER was measured on three 24-h urine collections; GFR was measured by 51Cr EDTA plasma clearance. A kidney biopsy was performed, and mesangial fractional volume [Vv(mes/glom)] and glomerular basement membrane (GBM) width were estimated by electron microscopic morphometric analysis. CRP, fibrinogen, SAA, and IL-6 differed among groups, with proteinuric patients having the highest levels. SAA and fibrinogen correlated with AER (P < 0.03 and P < 0.001, respectively). GBM width and Vv(mes/glom) increased from normoalbuminuric to proteinuric patients [P < 0.005 normoalbuminuric and microalbuminuric versus proteinuric for GBM, P < 0.01 normoalbuminuric versus proteinuric for Vv(mes/glom)]. In patients with increased GBM width (> 396 nm), CRP, SAA, and IL-6 were higher than in patients with normal GBM width (P < 0.003, P < 0.004, and P < 0.0004, respectively). GBM width was directly correlated with fibrinogen (r = 0.33, P < 0.002) and IL-6 (r = 0.25 P < 0.05). In conclusion, this study demonstrates that acute-phase markers of inflammation are associated with nephropathy status and GBM thickening, suggesting a role for inflammation in the pathogenesis of diabetic glomerulopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15938041     DOI: 10.1681/asn.2004110961

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  90 in total

Review 1.  Inflammation and diabetic nephropathy.

Authors:  Carmen Mora; Juan F Navarro
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 2.  The role of inflammation as a pathogenic factor in the development of renal disease in diabetes.

Authors:  Carmen Mora; Juan F Navarro
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

3.  Abnormal skeletal muscle capillary recruitment during exercise in patients with type 2 diabetes mellitus and microvascular complications.

Authors:  Lisa Womack; Dawn Peters; Eugene J Barrett; Sanjiv Kaul; Wendie Price; Jonathan R Lindner
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

Review 4.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

5.  Therapeutic effects of suppressors of cytokine signaling in diabetic nephropathy.

Authors:  Qingjuan Liu; Lingling Xing; Lei Wang; Fang Yao; Shuxia Liu; Jun Hao; Wei Liu; Huijun Duan
Journal:  J Histochem Cytochem       Date:  2013-11-11       Impact factor: 2.479

Review 6.  From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.

Authors:  Ying Qian; Eva Feldman; Subramanian Pennathur; Matthias Kretzler; Frank C Brosius
Journal:  Diabetes       Date:  2008-06       Impact factor: 9.461

7.  Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays.

Authors:  Wenbo Zhi; Ashok Sharma; Sharad Purohit; Eric Miller; Bruce Bode; Stephen W Anderson; John Chip Reed; R Dennis Steed; Leigh Steed; Diane Hopkins; Jin-Xiong She
Journal:  Mol Cell Proteomics       Date:  2011-09-06       Impact factor: 5.911

8.  Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes.

Authors:  Eun-Sil Yeo; Ji-Yun Hwang; Ji Eun Park; Young Ju Choi; Kap Bum Huh; Wha Young Kim
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

9.  A Study of Inflammatory Status in Nephropathy Patients with History of Type-II Diabetes Mellitus Undergoing Haemodialysis.

Authors:  Indrajit Nath; Chandan Kumar Nath; Mriganka Baruah; Moushumi Pathak; R Banerjee; Sapna Goyal
Journal:  J Clin Diagn Res       Date:  2013-10-05

10.  Combined body mass index with high-sensitivity C-reactive protein as independent predictors for chronic kidney disease in a relatively healthy population in Taiwan.

Authors:  Y-W Tsai; M-C Lu; Y-H Lin; Y-C Lee; W-C Li; J-Y Chen; S-S Chang
Journal:  Eur J Clin Nutr       Date:  2016-03-16       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.